Affordable EGFR-Targeted Treatment for Non-Small Cell Lung Cancer (NSCLC) and Advanced Pancreatic Cancer
Cancer treatment is rapidly shifting toward precision medicine, and Erlotinib Tablets have emerged as a highly effective targeted therapy for eligible patients diagnosed with EGFR-positive Non-Small Cell Lung Cancer (NSCLC) and certain cases of advanced pancreatic cancer.
Cordium Pharmaceuticals Pvt Ltd is a reliable pharmaceutical manufacturer and global exporter committed to supplying high-quality Erlotinib Tablets to healthcare providers, distributors, oncology centers, and importers worldwide.
We serve growing healthcare markets across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, South Africa, the USA, and the UK.
What are Erlotinib Tablets?
Erlotinib Tablets are prescription anti-cancer medicines that belong to a class called EGFR (Epidermal Growth Factor Receptor) Tyrosine Kinase Inhibitors (TKIs).
The medicine works by blocking abnormal proteins that stimulate cancer cell growth, helping to slow disease progression and improve treatment outcomes in selected patients.
Product Information
Generic Name: Erlotinib Hydrochloride
Dosage Strengths: 100 mg & 150 mg
Drug Category: Targeted Anti-Cancer Therapy (EGFR Inhibitor)
Administration: Oral Tablets
Medical Uses of Erlotinib Tablets
Treatment of EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC)
Erlotinib is widely used for patients diagnosed with:
- Metastatic Non-Small Cell Lung Cancer
- EGFR-positive lung cancer
- Advanced-stage NSCLC
- Maintenance therapy after initial treatment
- Patients unsuitable for certain chemotherapy regimens
Treatment of Advanced Pancreatic Cancer
Erlotinib may be prescribed alongside other anti-cancer treatments under specialist supervision for advanced pancreatic cancer management.
How Erlotinib Works Against Cancer Cells
Cancer cells depend on EGFR signals to multiply rapidly.
Erlotinib blocks these signals by inhibiting EGFR activity, which helps:
✅ Slow tumor growth
✅ Reduce cancer cell multiplication
✅ Delay disease progression
✅ Improve progression-free survival in eligible patients
Benefits of Choosing Erlotinib Tablets
Modern oncology specialists prefer targeted therapies because they focus on cancer-specific pathways.
Advantages include:
- Oral treatment for patient convenience
- Precision-based cancer management
- Effective for EGFR-positive patients
- Lower impact on healthy cells compared to some traditional treatments
- Easy daily administration
- Suitable for long-term treatment plans under physician guidance
Recommended Dosage of Erlotinib Tablets
Important: Dosage must always be determined by a qualified oncologist.
Non-Small Cell Lung Cancer
150 mg once daily
Advanced Pancreatic Cancer
100 mg once daily as prescribed in combination with other therapies.
Administration Guidelines
- Take on an empty stomach.
- Consume at the same time each day.
- Swallow whole with water.
- Do not crush, split, or chew tablets.
- Avoid self-medication.
Possible Side Effects of Erlotinib
Some patients may experience mild to moderate side effects.
Common Side Effects
- Skin rash
- Diarrhea
- Weakness
- Loss of appetite
- Dry skin
- Nausea
- Mouth ulcers
- Fatigue
Seek Immediate Medical Assistance If You Experience
- Severe breathing difficulty
- Persistent diarrhea
- Eye irritation or vision changes
- Serious skin reactions
- Signs of liver complications
Always consult an oncology specialist before starting or discontinuing treatment.
Why Healthcare Partners Choose Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is focused on delivering quality oncology solutions to global markets.
Our Key Advantages
✔ International export expertise
✔ Consistent product availability
✔ Affordable pricing structure
✔ Reliable bulk supply
✔ Strong distribution network
✔ Timely delivery support
✔ Dedicated customer assistance
✔ Long-term partnership opportunities
Global Markets We Serve
Cordium Pharmaceuticals Pvt Ltd supplies oncology medicines to healthcare organizations in:
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Southeast Asia
🇵🇭 Philippines
🇻🇳 Vietnam
Middle East
🇦🇪 United Arab Emirates (UAE)
🇸🇦 Saudi Arabia
Central Asia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Europe & North America
🇬🇧 United Kingdom
🇺🇸 United States
Who Can Partner With Cordium Pharmaceuticals?
We collaborate with:
- Oncology hospitals
- Pharmaceutical distributors
- Government healthcare agencies
- Cancer treatment centers
- Importers and wholesalers
- Institutional buyers
- Tender procurement companies
- Healthcare supply chains
Frequently Asked Questions
Is Erlotinib a chemotherapy medicine?
No. Erlotinib is a targeted therapy that specifically blocks EGFR pathways involved in cancer growth.
Who should take Erlotinib Tablets?
Only patients prescribed Erlotinib by an oncology specialist after proper diagnosis and testing.
Is genetic testing required before treatment?
EGFR mutation testing is commonly performed for lung cancer patients before initiating treatment.
Can Erlotinib be purchased internationally?
Yes. Cordium Pharmaceuticals Pvt Ltd supports international supply according to local regulatory requirements.
